T. Rowe Price Associates’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $298K | Buy |
|
|||||
|
2025
Q2 | $304K | Buy |
|
|||||
|
2025
Q1 | $199K | Buy |
|
|||||
|
2024
Q4 | $145K | Sell |
|
|||||
|
2024
Q3 | $281K | Sell |
|
|||||
|
2024
Q2 | $828K | Buy |
|
|||||
|
2024
Q1 | $667K | Buy |
|
|||||
|
2023
Q4 | $601K | Buy |
|
|||||
|
2023
Q3 | $187K | Sell |
|
|||||
|
2023
Q2 | $398K | Sell |
|
|||||
|
2023
Q1 | $304K | Buy |
|
|||||
|
2022
Q4 | $760K | Sell |
|
|||||
|
2022
Q3 | $785K | Buy |
|
|||||
|
2022
Q2 | $546K | Sell |
|
|||||
|
2022
Q1 | $926K | Sell |
|
|||||
|
2021
Q4 | $1.16M | Buy |
|
|||||
|
2021
Q3 | $1.77M | Sell |
|
|||||
|
2021
Q2 | $3.07M | Buy |
|
|||||
|
2021
Q1 | $4.82M | Buy |
|